Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€8.36

€8.36

-5.380%
-0.475
-5.380%
€31.73
 
16.10.25 / Frankfurt WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Omeros

sharewise wants to provide you with the best news and tools for Omeros, so we directly link to the best financial data sources.

News

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?: https://g.foolcdn.com/editorial/images/837965/individual-investor-looking-at-stock-charts-getty.jpg
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?

Shares of Omeros (NASDAQ: OMER) finished Oct. 14's trading session at $4.10 per share. When the market opened on Oct. 15, the stock was up by 181% at $11.52 per share.

It was a deal with the Danish

Omeros Posts 2,652 Percent Sales Jump
Omeros Posts 2,652 Percent Sales Jump

Omeros (NASDAQ:OMER), a biopharmaceutical company focused on developing treatments for rare diseases and immune-related conditions, released its second quarter results on August 14, 2025. The